← back to search

G d’Ancona

Guy's Hospital · GB
Area of research
Physiology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Asthma and respiratory diseases, Inhalation and Respiratory Drug Delivery, Eosinophilic Esophagitis, and Medication Adherence and Compliance.
h-index
20
citations
1,417
works
131
NIH funding
primary concept
email

Recent publications

Clinical and Biological Remission With Tezepelumab: The Real‐World Response in Severe Uncontrolled Asthma
Allergy 2025cited by 29position: middledoi
Long-Term Effectiveness of Benralizumab in Eosinophilic Granulomatosis With Polyangiitis
The Journal of Allergy and Clinical Immunology In Practice 2024cited by 29position: middledoi
Long-Term Effectiveness of Anti-IL-4R Therapy Following Suboptimal Response to Anti-IL-5/5R Therapy in Severe Eosinophilic Asthma
The Journal of Allergy and Clinical Immunology In Practice 2024cited by 28position: middledoi
The relationship between Feno and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthma
The Journal of Allergy and Clinical Immunology In Practice 2021cited by 64position: middledoi
Real-World Effectiveness of Anti–IL-5/5R Therapy in Severe Atopic Eosinophilic Asthma with Fungal Sensitization
The Journal of Allergy and Clinical Immunology In Practice 2021cited by 46position: middledoi
Prescribing Patterns and Treatment Adherence in Patients with Asthma During the COVID-19 Pandemic
The Journal of Allergy and Clinical Immunology In Practice 2021cited by 37position: middledoi
Adherence to inhaled corticosteroids and clinical outcomes following a year of benralizumab therapy for severe eosinophilic asthma
Allergy 2021cited by 32position: firstdoi
Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma
CHEST Journal 2020cited by 256position: middledoi
Real-World Effectiveness and the Characteristics of a “Super-Responder” to Mepolizumab in Severe Eosinophilic Asthma
CHEST Journal 2020cited by 203position: middledoi
Adherence to inhaled corticosteroids and clinical outcomes in mepolizumab therapy for severe asthma
European Respiratory Journal 2020cited by 86position: firstdoi
Benralizumab after sub‐optimal response to mepolizumab in severe eosinophilic asthma
Allergy 2020cited by 50position: middledoi
Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis
ERJ Open Research 2020cited by 38position: middledoi
Oral corticosteroid-sparing effects of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis
ERJ Open Research 2020cited by 35position: middledoi
Cost saving of switching to equivalent inhalers and its effect on health outcomes
Thorax 2019cited by 31position: middledoi
NREM parasomnias: a treatment approach based upon a retrospective case series of 512 patients
Sleep Medicine 2018cited by 70position: middledoi
Safety and efficacy of long-term use of sodium oxybate for narcolepsy with cataplexy in routine clinical practice
Sleep Medicine 2017cited by 46position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

David J. Jackson · Guy's Hospital13 papers (2020–2025)Alexandra M. Nanzer · Guy's Hospital12 papers (2020–2025)Linda K. Green · Columbia University12 papers (2020–2025)Jaideep Dhariwal · King's College London12 papers (2020–2025)Cris Roxas · St Thomas' Hospital12 papers (2020–2025)Louise Thomson · St Thomas' Hospital11 papers (2020–2024)Mariana Fernandes · St Thomas' Hospital10 papers (2020–2024)Joanne Kavanagh · King's College London9 papers (2020–2021)A Hearn · Emory Healthcare8 papers (2020–2024)Sangita Agarwal · Indian Institute of Science Education and Research Kolkata3 papers (2020–2024)Jessica Gates · King's College London3 papers (2024–2025) · 3 papers (2024–2025)Panagis Drakatos · Allen Institute for Brain Science2 papers (2017–2018)Seán Higgins · Guy's and St Thomas' NHS Foundation Trust2 papers (2017–2018) · 2 papers (2017–2018)Joerg Steier · King's College London2 papers (2017–2018)Adrian J. Williams · University of Arkansas for Medical Sciences2 papers (2017–2018)Ivana Rosenzweig · Allen Institute for Brain Science2 papers (2017–2018)Nadia Gildeh · King's College London2 papers (2017–2018)Rexford Muza · St Thomas' Hospital2 papers (2017–2018)